June 7, 2017 / 11:32 AM / 2 months ago

BRIEF-Proteostasis provides update on PTI-428 amplifier clinical data

June 7 (Reuters) - Proteostasis Therapeutics Inc

* PTI-428 amplifier clinical data in three separate populations of CF patients on track for mid-year

* PTI-801 new generation corrector phase 1 healthy volunteer sad study complete; mad study underway

* PTI-808 potentiator advancing to IND; DRF study intended to be POC for triple combination by year end 2017 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below